On April 14, USC Verdugo Hills Hospital (USC-VHH) welcomed 40 high school students from five local schools for its annual ...
BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) is a biopharmaceutical company that is developing treatments for infectious diseases and other illnesses. Recently, BiondVax signed definitive agreements ...
BOSTON, June 17, 2025--(BUSINESS WIRE)--Abcore®, a brand operating within the Antibody Solutions (AbS) business division as a part of Fortis Life Sciences®, an innovation leader in VHH discovery and ...
Antibody discovery is at the core of therapeutics research. VHH antibodies, also known as single-domain antibodies, offer a smaller, engineerable alternative to traditional antibodies, overcoming many ...
Dr. Dave Fancy discusses the common challenges that scientists face when developing nanobodies and how anti-alpaca secondary antibodies can be used to produce high-affinity nanobodies and VHH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results